直接抗凝治疗对心房动的血液学参数的影响:亚临床血红蛋白降低的临床意义
Metin Çoksevim1, İdris Buğra Çerik2, Ömer Kertmen3
1Department of Cardiology, School of Medicine, Ondokuz Mayıs University, 55200 Samsun, Turkey.
Medicina (Kaunas, Lithuania)
|November 27, 2024
概括
直接口服抗凝剂 (DOACs) 可能导致心房患者的血红蛋白降低. 较高的基线血红蛋白预测更大的减少,需要监测,即使在稳定的AF患者在DOAC治疗.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
背景情况:
- 直接口服抗凝剂 (DOAC) 对于预防心房动 (AF) 中的中风至关重要.
- 关于DOACs对稳定的AF患者血液学参数的影响的研究有限.
- 在接受DOAC治疗的AF患者中调查血红蛋白 (Hb) 变化是很重要的.
研究的目的:
- 分析关键血液学参数的变化,重点关注Hb.
- 评估在接受DOACs的临床稳定的AF患者中的Hb变化.
主要方法:
- 对530名AF患者在DOAC上进行的回顾性研究.
- 基于一年后的Hb变化 (ΔHb < 2g/dL对 ΔHb ≥ 2g/dL) 的分类.
- 对基线Hb的分析及其对Hb下降的预测值.
主要成果:
- 患有ΔHb≥2g/dL的患者基线Hb水平较高 (14.6g/dL与13.5g/dL相比).
- 较高的基线血是≥2g/dL血下降的显著预测因素 (OR,1.424).
- 这一趋势在不同的DOAC和剂量中是一致的.
结论:
- 对于接受DOAC治疗的患者来说,对贫血的警监测至关重要.
- 即使在临床上稳定的AF患者也需要监测潜在的Hb降低.
- 基线Hb水平可能表明在DOAC治疗期间Hb显著下降的风险.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
01:24Disorders of Hemostasis
710
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
710